DK413883A - Fremgangsmaade til fremstilling af c-20-modificerede macrolidderivater eller farmaceutisk acceptable salte deraf - Google Patents

Fremgangsmaade til fremstilling af c-20-modificerede macrolidderivater eller farmaceutisk acceptable salte deraf Download PDF

Info

Publication number
DK413883A
DK413883A DK413883A DK413883A DK413883A DK 413883 A DK413883 A DK 413883A DK 413883 A DK413883 A DK 413883A DK 413883 A DK413883 A DK 413883A DK 413883 A DK413883 A DK 413883A
Authority
DK
Denmark
Prior art keywords
preparing
procedure
acceptable salts
pharmaceutical acceptable
macrolide derivatives
Prior art date
Application number
DK413883A
Other languages
English (en)
Other versions
DK413883D0 (da
Inventor
Herbert Andrew Kirst
John Eldon Toth
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK413883D0 publication Critical patent/DK413883D0/da
Publication of DK413883A publication Critical patent/DK413883A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
DK413883A 1982-09-13 1983-09-12 Fremgangsmaade til fremstilling af c-20-modificerede macrolidderivater eller farmaceutisk acceptable salte deraf DK413883A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/417,248 US4443436A (en) 1982-09-13 1982-09-13 C-20-Modified macrolide derivatives of the macrolide antibiotics tylosin, desmycosin, macrocin, and lactenocin

Publications (2)

Publication Number Publication Date
DK413883D0 DK413883D0 (da) 1983-09-12
DK413883A true DK413883A (da) 1984-03-14

Family

ID=23653187

Family Applications (1)

Application Number Title Priority Date Filing Date
DK413883A DK413883A (da) 1982-09-13 1983-09-12 Fremgangsmaade til fremstilling af c-20-modificerede macrolidderivater eller farmaceutisk acceptable salte deraf

Country Status (17)

Country Link
US (1) US4443436A (da)
EP (2) EP0203621B1 (da)
JP (1) JPS5973599A (da)
KR (1) KR850001952B1 (da)
AT (1) AT381708B (da)
AU (1) AU565892B2 (da)
CA (1) CA1229336A (da)
DE (2) DE3381289D1 (da)
DK (1) DK413883A (da)
GB (1) GB2127018B (da)
GR (1) GR78989B (da)
HU (1) HUT35274A (da)
IE (1) IE55917B1 (da)
IL (1) IL69667A0 (da)
NZ (1) NZ205502A (da)
PH (1) PH19760A (da)
ZA (1) ZA836742B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820695A (en) * 1982-09-13 1989-04-11 Eli Lilly And Company C-20-dihydro-deoxy-(cyclic amino)-derivatives of macrolide antibiotics
US4629786A (en) * 1983-02-28 1986-12-16 Eli Lilly And Company C-20- and C-23 modified macrolide derivatives
IL71032A0 (en) * 1983-02-28 1984-05-31 Lilly Co Eli C-20 and c-23-modified macrolide derivatives
GB8405087D0 (en) * 1984-02-27 1984-04-04 Omura S Antibiotic
US4921947A (en) * 1986-03-31 1990-05-01 Eli Lilly And Company Process for preparing macrolide derivatives
EP0262903A3 (en) * 1986-09-29 1988-11-02 Eli Lilly And Company New acyl derivatives of 20-modified tylosin and desmycosin compounds
US4920103A (en) * 1986-09-29 1990-04-24 Eli Lilly And Company Modifications of mycinose and 3-O-demethylmycinose in tylosin-type macrolides
US4820694A (en) * 1986-09-29 1989-04-11 Eli Lilly And Company Modifications of 3-O-demethylmycinose in macrocin and lactenocin
SI8710674B (sl) * 1987-04-14 1998-06-30 Pliva Postopek za pripravo 10,11,12,13-tetrahidro derivatov tilozina
ATE150757T1 (de) * 1992-01-14 1997-04-15 Zaidan Hojin Biseibutsu 3,4'-didesoxymycaminosyltylonolid-derivate und herstellung davon
US5354708A (en) * 1992-06-04 1994-10-11 Taskar Nikhil R Method of nitrogen doping of II-VI semiconductor compounds during epitaxial growth using an amine
TW226373B (da) * 1992-07-15 1994-07-11 Pfizer
AU3121095A (en) * 1994-09-22 1996-04-09 Pfizer Inc. Antibiotic macrolides
AU2014270353B2 (en) * 2013-05-23 2018-09-20 Elanco Animal Health Gmbh Tylosin derivatives and method for preparation thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1278441B (de) * 1958-10-29 1968-09-26 Lilly Co Eli Verfahren zur Herstellung von Acylderivaten von Tylosin und Desmycosin und deren Salzen
US3178341A (en) * 1960-06-27 1965-04-13 Lilly Co Eli Antibiotics tylosin and desmycosin and derivatives thereof
US3326759A (en) * 1962-07-19 1967-06-20 Lilly Co Eli Antibiotics macrocin and lactenocin
JPS5321182A (en) * 1976-08-10 1978-02-27 Sanraku Inc Antibiotic angolamycin derivatives and their preparation
GB1587685A (en) * 1977-03-09 1981-04-08 Microbial Chem Res Found Macrolactone derivatives and their production
JPS53130686A (en) * 1977-04-19 1978-11-14 Toyo Jozo Co Ltd 17-deformyl-17-thiazolidyl macrolide antibiotics
JPS53132584A (en) * 1977-04-26 1978-11-18 Toyo Jozo Co Ltd 18-cyano-18-substituted amino-18-deoxy-macrolide anibiotic substance derivative
SE445739B (sv) * 1978-09-14 1986-07-14 Toyo Jozo Kk 3", 4"-diacyltylosinderivat
JPS5655399A (en) * 1979-09-19 1981-05-15 Toyo Jozo Co Ltd Deformyltylosin derivative
NL8004922A (nl) * 1979-09-19 1981-03-23 Toyo Jozo Kk Deformyltylosinederivaten.
JPS5671099A (en) * 1979-11-13 1981-06-13 Toyo Jozo Co Ltd 20-deoxodesmycosin
US4321361A (en) * 1980-06-12 1982-03-23 Eli Lilly And Company Demycinosyltylosin and process for its production
US4279896A (en) * 1980-06-23 1981-07-21 Schering Corporation Novel 20-imino macrolide antibacterial agents
US4349665A (en) * 1980-06-27 1982-09-14 Schering Corporation Macrolide antibiotic complex
HU189519B (en) * 1980-07-24 1986-07-28 Eli Lilly And Co,Us Process for preparing 2'''-o-demethyl-macrocin derivatives
US4299953A (en) * 1980-07-29 1981-11-10 Eli Lilly And Company Mycarosyltylactone
US4304856A (en) * 1980-11-10 1981-12-08 Eli Lilly And Company Process for producing 20-dihydro-20-deoxy-23-demycinosyltylosin
US4357325A (en) * 1981-04-20 1982-11-02 Eli Lilly And Company Methods of controlling Pasteurella infections
US4401660A (en) 1981-12-14 1983-08-30 Eli Lilly And Company Ester derivatives of 5-O-mycaminosyl tylonolide and method of using same
JPS58146595A (ja) * 1982-02-25 1983-09-01 Satoshi Omura マクロライド系抗生物質

Also Published As

Publication number Publication date
KR840005735A (ko) 1984-11-15
EP0203621B1 (en) 1990-03-07
IE55917B1 (en) 1991-02-27
EP0203621A1 (en) 1986-12-03
AU1871183A (en) 1984-03-22
ZA836742B (en) 1984-04-25
GB2127018B (en) 1986-02-12
AU565892B2 (en) 1987-10-01
EP0104028B1 (en) 1988-08-03
AT381708B (de) 1986-11-25
GB2127018A (en) 1984-04-04
GB8324045D0 (en) 1983-10-12
US4443436A (en) 1984-04-17
JPH0517240B2 (da) 1993-03-08
CA1229336A (en) 1987-11-17
DE3381289D1 (de) 1990-04-12
JPS5973599A (ja) 1984-04-25
GR78989B (da) 1984-10-02
IE832132L (en) 1984-03-13
PH19760A (en) 1986-06-26
NZ205502A (en) 1986-03-14
KR850001952B1 (ko) 1985-12-31
ATA320783A (de) 1986-04-15
IL69667A0 (en) 1983-12-30
DE3377576D1 (en) 1988-09-08
DK413883D0 (da) 1983-09-12
EP0104028A1 (en) 1984-03-28
HUT35274A (en) 1985-06-28

Similar Documents

Publication Publication Date Title
DK146482A (da) Fremgangsmaade til fremstilling af cyklobutylaminderivater eller farmaceutisk acceptable salte deraf
DK149449C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater eller farmaceutisk acceptable salte deraf
DK28282A (da) Fremgangsmaade til fremstilling af hexapyranoseforbindelser eller salte deraf
DK552581A (da) Fremgangsmaade til fremstilling af 3-pyridylaklyl-indol-forbindelser eller farmaceutisk acceptable salte deraf
DK161968C (da) Analogifremgangsmaade til fremstilling af imidazo-pyrazolo-pyrimidiner eller farmaceutisk acceptable salte deraf
DK503080A (da) Fremgangsmaade til fremstilling af imdazolderivater eller salte deraf
DK413883A (da) Fremgangsmaade til fremstilling af c-20-modificerede macrolidderivater eller farmaceutisk acceptable salte deraf
DK294780A (da) Fremgangsmaade til fremstilling af trans-3-(4-oxo4h-quinazolin-3-yl)-2-propensyrederivater eller salte deraf
DK493083A (da) Fremgangsmaade til fremstilling af 4-oxo-1,4-dihydronicotinsyrederivater eller salte deraf
DK159427C (da) Analogifremgangsmaade til fremstilling af antiallergisk virksomme quinolinonderivater eller salte deraf
DK158306C (da) Analogifremgangsmaade til fremstilling af substituerede pyridylallylforbindelser eller farmaceutisk acceptable salte deraf
DK297382A (da) Fremgangsmaade til fremstilling af 3-(3-(heteroarylalkyl)-1-indolyl)acryl-syre-derivater eller farmaceutisk acceptable salte deraf
DK158658C (da) Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf
DK358183D0 (da) Fremgangsmade til fremstilling af alfa-aryl-alkansyrer eller salte deraf
DK232777A (da) Fremgangsmade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
DK475982A (da) Fremgangsmaade til fremstilling af benzofuranoner eller salte deraf
DK232677A (da) Fremgangsmade til fremstilling af dihydro eller tetrahydroiminothiaziner eller farmaceutisk acceptable salte deraf
DK165983C (da) Fremgangsmaade til fremstilling af phosphorholdige antibiotiske forbindelser betegnet cl 1565-a, cl 1565-b og cl 1565-t eller farmaceutisk acceptable salte deraf
DK232877A (da) Fremgangsmade til fremstilling af 2-imino-3-aminothiazolidiner eller farmaceutisk acceptable salte deraf
DK210183A (da) Fremgangsmaade til fremstilling af piperidinoquinazolin-forbindelser eller farmaceutisk acceptable salte deraf
DK149823C (da) Fremgangsmaade til fremstilling af kijanimicin eller farmaceutisk acceptable salte heraf
DK224381A (da) Fremgangsmaade til fremstilling af benzazolderivater eller salte deraf
DK300280A (da) Fremgangsmaade til fremstilling af tetrahydropyridin-4-ylindolderivater eller salte deraf
ES534349A0 (es) Procedimiento para preparar nuevos derivados de piperidina
DK151254C (da) Analogifremgangsmaade til fremstilling af 2-hydroxymethyl-pyrazin-derivater eller farmaceutisk acceptable salte deraf

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment